{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:41:16Z","timestamp":1648838476396},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,10,21]],"date-time":"2012-10-21T00:00:00Z","timestamp":1350777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00059-012-3691-0","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T07:24:33Z","timestamp":1350890673000},"page":"728-734","source":"Crossref","is-referenced-by-count":2,"title":["Nichtmedikament\u00f6se und medikament\u00f6se Therapie bei arterieller Hypertonie"],"prefix":"10.1007","volume":"37","author":[{"given":"J.","family":"Hoyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,21]]},"reference":[{"key":"3691_CR1","unstructured":"Deutsche Hochdruckliga (2009) Leitlinien zur Behandlung der arteriellen Hypertonie. Nieren- und Hochdruckkrankheiten 38:137\u2013188"},{"key":"3691_CR2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"Task","year":"2007","unstructured":"Task force for management of arterial hypertension of ESH and ESC (2007) 2007 guidelines for management of hypertension. J Hypertens 25:1105\u20131187","journal-title":"J Hypertens"},{"key":"3691_CR3","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","volume":"27","author":"Mancia","year":"2009","unstructured":"Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27(11):2121\u20132158","journal-title":"J Hypertens"},{"key":"3691_CR4","unstructured":"National Health Service, National Institute for Health and Clinical Excellence (2011) NICE guidelines CG127: Hypertension 2011. http:\/\/publications.nice.org.uk\/hypertension-cg127"},{"key":"3691_CR5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cjca.2012.02.018","volume":"28","author":"Daskalopoulou","year":"2012","unstructured":"Daskalopoulou S, Khan N, Quinn R et al (2012) The 2012 Canadian hypertension education program recommendations for the management of hypertension. Can J Cardiol 28:270\u2013287","journal-title":"Can J Cardiol"},{"key":"3691_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00004872-199715060-00001","volume":"15","author":"Jennings","year":"1997","unstructured":"Jennings GLR (1997) Exercise and blood pressure: walk, run or swim? J Hypertens 15:567\u2013569","journal-title":"J Hypertens"},{"key":"3691_CR7","first-page":"187","volume":"12","author":"Reid","year":"1994","unstructured":"Reid CM, Dart AM, Dewar EM et al (1994) Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects. J Hypertens 12:187\u2013193","journal-title":"J Hypertens"},{"key":"3691_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrneph.2012.91","volume":"8","author":"Mohanlal","year":"2012","unstructured":"Mohanlal V, Parsa A, Weir MR (2012) Role of dietary therapies in the prevention and treatment of hypertension. Nat Rev Nephrol 8:413\u2013422","journal-title":"Nat Rev Nephrol"},{"key":"3691_CR9","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMct0911013","volume":"362","author":"Sacks","year":"2010","unstructured":"Sacks FM, Campos H (2010) Dietary therapy in hypertension. N Engl J Med 362:2102\u20132112","journal-title":"N Engl J Med"},{"key":"3691_CR10","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206\u20131252","journal-title":"Hypertension"},{"key":"3691_CR11","first-page":"457","volume":"107","author":"Klaus","year":"2010","unstructured":"Klaus D, Hoyer J, Middeke M (2010) Kochsalzrestriktion zur Pr\u00e4vention kardiovaskul\u00e4rer Erkrankungen. Dtsch Aerztebl 107:457\u2013462","journal-title":"Dtsch Aerztebl"},{"key":"3691_CR12","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1056\/NEJMp1110421","volume":"365","author":"Frieden","year":"2011","unstructured":"Frieden TR, Berwick BM (2011) The\u201cMillion Hearts\u201d initiative \u2013 preventing heart attacks and stroke. N Engl J Med 365:e27(1\u20134)","journal-title":"N Engl J Med"},{"key":"3691_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.HYP.37.2.187","volume":"37","author":"Primatesta","year":"2001","unstructured":"Primatesta P, Falaschetti E, Gupta S et al (2001) Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 37:187\u2013193","journal-title":"Hypertension"},{"key":"3691_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","volume":"47","author":"Ernst","year":"2006","unstructured":"Ernst ME, Carter BL, Goerdt CJ et al (2006) Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:352\u2013358","journal-title":"Hypertension"},{"key":"3691_CR15","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"Jackson","year":"2002","unstructured":"Jackson T, Wright JR, The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group et al (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981\u20132196","journal-title":"JAMA"},{"key":"3691_CR16","first-page":"CD","volume":"8","author":"Wiysonge","year":"2012","unstructured":"Wiysonge CS, Bradley HA, Volmink J et al (2012) Beta-blockers for hypertension. Cochrane Database Syst Rev 8:CD 002003","journal-title":"Cochrane Database Syst Rev"},{"key":"3691_CR17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","volume":"13","author":"Elliott","year":"2011","unstructured":"Elliott EJ, Ram CV (2011) Calcium channel blockers. J Clin Hypertens 13:687\u2013689","journal-title":"J Clin Hypertens"},{"key":"3691_CR18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(07)61299-9","volume":"370","author":"Messerli","year":"2007","unstructured":"Messerli F, Williams B, Ritz E (2007) Essential hypertension. Lancet 370:593\u2013603","journal-title":"Lancet"},{"key":"3691_CR19","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL et al (2008) Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359(23):2417\u20132428","journal-title":"N Engl J Med"},{"key":"3691_CR20","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/eurheartj\/ehl308","volume":"27","author":"Messerli","year":"2006","unstructured":"Messerli FH, Mancia G, Conti CR et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. Eur Heart J 27(23):2902\u20132903","journal-title":"Eur Heart J"},{"key":"3691_CR21","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJMcp1107281","volume":"366","author":"Davis","year":"2012","unstructured":"Davis SM, Donnan GA (2012) Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med 366:1914\u20131922","journal-title":"N Engl J Med"},{"key":"3691_CR22","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","volume":"359","author":"Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA et al (2008) Long term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 359:1565\u20131576","journal-title":"N Engl J Med"},{"key":"3691_CR23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1751-7176.2011.00448.x","volume":"13","author":"Ritz","year":"2011","unstructured":"Ritz E (2011) Drug of choice in the management of hypertension in diabetes and diabetic nephropathy: angiotensin-converting enzyme inhibitors. Clin J Hypertens 13:285\u2013289","journal-title":"Clin J Hypertens"},{"key":"3691_CR24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","volume":"380","author":"Ferrannini","year":"2012","unstructured":"Ferrannini E, Cushmann WC (2012) Diabetes and hypertension: the bad companions. Lancet 380:601\u2013610","journal-title":"Lancet"},{"key":"3691_CR25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/ki.2010.292","volume":"78","author":"Bakris","year":"2011","unstructured":"Bakris G, Vassalotti J, Ritz E et al (2011) National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events. Kidney Int 78:726\u2013736","journal-title":"Kidney Int"},{"key":"3691_CR26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","volume":"365","author":"Ruggenenti","year":"2005","unstructured":"Ruggenenti P, Perna A, Loriga G et al (2005) Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 365:939\u2013946","journal-title":"Lancet"},{"key":"3691_CR27","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1055\/s-0031-1272580","volume":"136","author":"Mahfoud","year":"2011","unstructured":"Mahfoud F, Vonend O, Bruck H et al (2011) Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie. Dtsch Med Wochenschr 136:2418\u20132424","journal-title":"Dtsch Med Wochenschr"},{"key":"3691_CR28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","volume":"58","author":"Bisognano","year":"2011","unstructured":"Bisognano JD, Bakris G, Nadim MK et al (2011) Baroflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol 58:765\u2013773","journal-title":"J Am Coll Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-012-3691-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3691-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T15:56:36Z","timestamp":1558540596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-012-3691-0"}},"subtitle":["Aktueller Stand"],"short-title":[],"issued":{"date-parts":[[2012,10,21]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["3691"],"URL":"https:\/\/doi.org\/10.1007\/s00059-012-3691-0","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,21]]}}}